The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diabetes Mellitus and Albuminuria

NCT06611904 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Urine Albumin (UAlb)
Glycocalyx
Arterial Stiffness

Interventions

DRUG: Dulaglutide
DRUG: DPP-4 Inhibitors

Sponsor

Attikon Hospital